Hohimer Wealth Management’s Novo Nordisk NVO Stock Holding History

Hohimer Wealth Management’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.2M	Buy	87,664 +60,247	+220%	+$2.59M	0.42%	66
2026 Q1	$1.01M	Sell	27,417 -36,346	-57%	-$1.72M	0.12%	160
2025 Q4	$3.24M	Buy	63,763 +35,381	+125%	+$1.81M	0.44%	75
2025 Q3	$1.57M	Buy	28,382 +20,038	+240%	+$1.17M	0.22%	120
2025 Q2	$576K	Sell	8,344 -129	-2%	-$8.78K	0.1%	148
2025 Q1	$588K	Buy	+8,473	New	+$700K	0.11%	143
2024 Q4	–	Sell	-8,391	Closed	-$999K	–	258
2024 Q3	$999K	Buy	8,391 +287	+4%	+$38.3K	0.21%	114
2024 Q2	$1.16M	Buy	+8,104	New	+$1.07M	0.27%	99

Other funds holding NVO

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Hohimer Wealth Management's NVO Position: Q2 2026 in Review

Hohimer Wealth Management increased its Novo Nordisk (NVO) stake by 220% in Q2 2026, buying an estimated $2.59M and bringing the position to 87,664 shares worth $4.2M. The position accounts for 0.42% of the portfolio, ranked #66.

Hohimer Wealth Management first reported a position in NVO in Q2 2024 and has held it in 8 quarters since. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

Hohimer Wealth Management held 87,664 shares of Novo Nordisk worth $4.2M as of Q2 2026.
Hohimer Wealth Management bought 60,247 Novo Nordisk shares in Q2 2026, an estimated $2.59M.
Novo Nordisk made up 0.42% of Hohimer Wealth Management's portfolio in Q2 2026, its #66 holding.
Hohimer Wealth Management first reported a position in Novo Nordisk in Q2 2024 and has held it in 8 quarters since.
1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Hohimer Wealth Management's 13F filing for Q2 2026, filed 3 Aug 2026.